Celldex Therapeutics, a biopharmaceutical company focused on developing antibody-based therapies for treating allergic, inflammatory and autoimmune disorders, signed a new lease to expand by 40,600 square feet at Perryville III, a three-level suburban office complex in Hampton, New Jersey.
Celldex scales office footprint to support clinical development programs
Biopharmaceutical company more than doubles its space at the Perryville Corporate Park
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Properties
- Perryville III
53 Frontage Rd, Hampton, NJ
- Companies
- Shelbourne Global Solutions, LLC
Real Estate
- Contacts
- William O'Keefe
Executive Director, Cushman & Wakefield
- Thomas O'Keefe
Associate, Cushman & Wakefield
- Charles Parmelli
Executive Managing Director, Cushman & Wakefield